Serum Calprotectin and Iron Metabolism Biomarker Levels in Behcet's Disease
dc.authorid | DOGAN, Halef Okan/0000-0001-8738-0760 | |
dc.authorid | KARADAG, Ahmet/0000-0002-5284-2256 | |
dc.contributor.author | Karadag, Ahmet | |
dc.contributor.author | Dogan, Halef Okan | |
dc.date.accessioned | 2024-10-26T18:00:30Z | |
dc.date.available | 2024-10-26T18:00:30Z | |
dc.date.issued | 2021 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Objective: This study aimed to investigate the serum levels of calprotectin, hepcidin, iron, and ferritin in Behcet's disease (BD). Materials and Methods: This study included 40 patients with BD who met the diagnostic criteria of the BD International Study Group (1990) and 40 healthy control participants. Serum high-sensitive C-reactive protein (hsCRP), hepcidin, calprotectin, ferritin, iron, and unsaturated iron-binding capacity (UIBC) levels were determined in all study participants. Results: Statistically significant difference was found between the groups in respect of calprotectin (p<0.05), UIBC (p<0.05), hsCRP (p<0.05), and hemoglobin (p<0.05) levels. No statistically significant differences were determined between the patients and the controls in terms of hepcidin, iron, and ferritin levels. Cut-off value of 212.3 pg/mL for calprotectin was determined to identify patients with BD having a sensitivity and specificity of 100% and 90%, respectively. Conclusion: Serum calprotectin may be a useful biomarker in the evaluation of inflammatory status and BD diagnosis. Total iron-binding capacity and hemoglobin may be more useful in evaluating iron deficiency anemia in patients with BD. | |
dc.identifier.doi | 10.4274/tod.galenos.2021.45403 | |
dc.identifier.endpage | 144 | |
dc.identifier.issn | 2147-2653 | |
dc.identifier.issue | 3 | |
dc.identifier.scopus | 2-s2.0-85123835633 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 140 | |
dc.identifier.trdizinid | 527464 | |
dc.identifier.uri | https://doi.org/10.4274/tod.galenos.2021.45403 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/527464 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/27722 | |
dc.identifier.volume | 27 | |
dc.identifier.wos | WOS:000753766500003 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | |
dc.publisher | Galenos Yayincilik | |
dc.relation.ispartof | Turk Osteoporoz Dergisi-Turkish Journal of Osteoporosis | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Behcet's disease | |
dc.subject | calprotectin | |
dc.subject | hepcidin | |
dc.subject | iron | |
dc.subject | ferritin | |
dc.title | Serum Calprotectin and Iron Metabolism Biomarker Levels in Behcet's Disease | |
dc.type | Review Article |